Healthcare -
Biotechnology - NASDAQ - US
$ 21.06
1.1 %
$ 1.03 B
Market Cap
-11.14
P/E
ELVN - OPERATING EXPENSES
Operating Expenses ELVN - Enliven Therapeutics, Inc.
83.5 M
LAST VALUE
83.66%
2 YEAR CAGR
50.90%
5 YEAR CAGR
0.00%
10 YEAR CAGR